Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2022-05-10 | 2022-03 | -0.12 | N/A | N/A | N/A |
2022-03-28 | 2021-12 | -0.13 | N/A | N/A | N/A |
2021-11-10 | 2021-09 | -0.47 | N/A | N/A | N/A |
2021-08-12 | 2021-06 | -0.8 | N/A | N/A | N/A |
2021-05-13 | 2021-03 | -0.83 | N/A | N/A | N/A |
2021-03-18 | 2020-12 | -0.76 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2021-10-14 | HC Wainwright & Co. | Upgrade | Buy | |
2021-06-03 | Raymond James | Downgrade | Outperform | Market Perform |
2021-06-03 | Baird | Downgrade | Outperform | Neutral |
2021-05-17 | Wells Fargo | Upgrade | Underweight | |
2021-05-14 | Raymond James | Upgrade | Outperform | |
2021-02-08 | Wells Fargo | Downgrade | Overweight | Underweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-06-13 | ATHYRIUM OPPORTUNITIES FUND A, L.P. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
2021-06-13 | BIGALKE JOHN T | Director | 47.52K | Stock Award(Grant) |
2022-04-14 | D'ESPARBES ERIC | Chief Financial Officer | 423.17K | Stock Award(Grant) |
2021-11-02 | HOWE JILL ANN | Director | 76.75K | Stock Award(Grant) |
2021-06-13 | KOTZIN BRIAN L | Director | 47.52K | Stock Award(Grant) |
2021-11-07 | MOHANTY ADITYA P | Chief Executive Officer | 1.41M | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2021-12-30 | Athyrium Capital Management, LP | 29.86M | 62.40M | 16.21% |
2022-03-30 | Neuberger Berman Group, LLC | 6.54M | 7.59M | 3.55% |
2022-03-30 | Vanguard Group, Inc. (The) | 5.16M | 5.98M | 2.80% |
2022-03-30 | Blackrock Inc. | 1.66M | 1.93M | 0.90% |
2022-03-30 | Geode Capital Management, LLC | 1.15M | 1.34M | 0.63% |
2022-03-30 | Susquehanna International Group, LLP | 955.32K | 1.11M | 0.52% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2021-12-30 | Vanguard Total Stock Market Index Fund | 3.03M | 6.32M | 1.64% |
2021-12-30 | Vanguard Extended Market Index Fund | 1.58M | 3.29M | 0.86% |
2022-02-27 | Fidelity Extended Market Index Fund | 615.33K | 830.69K | 0.33% |
2022-02-27 | Fidelity Total Market Index Fund | 210.77K | 284.53K | 0.11% |
2022-02-27 | Fidelity Series Total Market Index Fund | 121.33K | 163.79K | 0.07% |
2022-02-27 | Fidelity NASDAQ Composite Index Fund | 80.80K | 109.08K | 0.04% |
-
I loved this stock a lot sub $1. This is going down -10% daily. Chart looks horrible.
-
I am very bullish at $0.86. Come down to papa.
-
It is actually smarter to sell at $2, so that now you can buy back a lot more shares. Think about it. Use a calculator if you can’t think.
-
None of Gradoth predictions have proven yet. Only bleeding at this point.
-
There is no ripping. There is only bleeding right now. Just make sure you don’t bleed out. Otherwise, you won’t be there for the real ripping.
-
Never catch a falling knife. Also never stand in the way of a falling knife. Get out so you can buy back twice amount of shares sub $1
-
Without buying volumes, this stock will continue downtrend. If you sold at $2, now you would be able to buy more shares back than you previously owned. Way better than trying to average down or buy dip. But this will go sub $1. Just be patient.
-
-
Ssr is fake. Dark pool and fresh are real. Dump now to buy back twice amount of shares below $1
-
Imminent bloodbath. I told u so. Get out so you can buy back twice amount of shares below $1
-
COVID is back. Uncertainty is high. Drug price uncertainties are high right now. That’s why biotech are underperforming.
-
Yes you don’t lose a dime either by selling now so that you can buy back twice the amount of shares below $1. Don’t listen to these bag holders and pumpers. Protect your ASSETS.
-
I am bullish. But the stock has been proven Bullshi-s for past 3 months. Invest on facts and not hypes. The chart speaks for itself.
-
Gradoth has been imminently wrong on all his predictions. I wouldn’t trust my money with his predictions whatsoever. Dude doesn’t own a magic crystal ball
-
Everyone has 2 options. Continue to hold and bleed down to sub $1. Or get out now so that you can buy back twice the amount of shares sub $1. Your money. Your choice.
-
The pumpers with average below $1 are telling everyone to hold for them. Don’t be stupid bleeding for these YouTube pumpers.
-
Guess what happens when everyone pulls their money out and no buyers show up, the stock will tank. Your single buying will not do anything. Think smart. Think like Hedgies.
-
There is nothing wrong with pulling money out at this point. So that you can buy more shares below $1. You won’t have enough money to average down below $1
-
When you bear your ASSets around town, flies and maggots tend to follow and stalk.
-
COVID is back and surging nationwide. Fears and Volatility will continue to drive small caps and high risk stocks to the downside. Don’t be stupid holding. This stock will go below $1. Don’t stand in the way of a falling knife. And don’t catch a falling knife either.
-
Progenity Announces Successful Transfer of Liquid Biopsy Technologies
globenewswire.com • -
Progenity to Become Biora Therapeutics as it Completes Transformation
globenewswire.com • -
Progenity Announces Two Poster Presentations at Controlled Release Society 2022
globenewswire.com • -
Should You Invest in These Penny Stocks Next Month? 3 to Watch
pennystocks.com • -
Penny Stocks To Buy Now? 4 Short Squeeze Stocks To Watch This Week
pennystocks.com • -
Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022
globenewswire.com • -
Top Penny Stocks to Buy Right Now? 3 to Watch in Mid-February
pennystocks.com • -
Top Reddit Penny Stocks That Investors Are Watching Right Now
pennystocks.com • -
3 Penny Stocks Climbing During Today's Trading Session
pennystocks.com • -
These 4 Penny Stocks Exploded Today, Here's Why
pennystocks.com • -
Here's 3 Trending Penny Stocks to Add to Your Watchlist in February
pennystocks.com • -
5 Top Penny Stocks To Buy Now According To Reddit
pennystocks.com •